Zobrazeno 1 - 10
of 89
pro vyhledávání: '"van Bree N"'
Autor:
van Bree N; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden., Oppelt AS; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden., Lindström S; Comparative Medicine, Karolinska Institutet, 171 65 Stockholm, Sweden., Zhou L; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden., Boutin L; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden., Coyle B; Children's Brain Tumour Research Centre, School of Medicine, Biodiscovery Institute, University Park, University of Nottingham, Nottingham NG7 2RD, UK., Swartling FJ; Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden., Johnsen JI; Department of Women's and Children's Health, Karolinska Institutet, 171 65 Stockholm, Sweden., Bräutigam L; Comparative Medicine, Karolinska Institutet, 171 65 Stockholm, Sweden., Wilhelm M; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2024 Oct 09. Date of Electronic Publication: 2024 Oct 09.
Autor:
Zhou L; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., van Bree N; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., Boutin L; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., Ryu J; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., Moussaud S; Chemical Biology Consortium Sweden (CBCS), Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Liu M; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., Otrocka M; Chemical Biology Consortium Sweden (CBCS), Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Olsson M; Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden., Falk A; Department of Experimental Medical Science, Lund Stem Cell Center, Lund University, Lund, Sweden.; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden., Wilhelm M; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2024 Sep 05; Vol. 26 (9), pp. 1685-1699.
Autor:
Wolfsberger J; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 65 Stockholm, Sweden., Sakil HAM; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 65 Stockholm, Sweden., Zhou L; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 65 Stockholm, Sweden., van Bree N; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 65 Stockholm, Sweden., Baldisseri E; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 65 Stockholm, Sweden., de Souza Ferreira S; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, 171 65, Sweden., Zubillaga V; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 65 Stockholm, Sweden., Stantic M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 65 Stockholm, Sweden., Fritz N; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 65 Stockholm, Sweden., Hartman J; Department of Oncology-Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden., Rolny C; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, 171 65, Sweden., Wilhelm MT; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 65 Stockholm, Sweden; margareta.wilhelm@ki.se.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Mar 09; Vol. 118 (10).
Autor:
Susanto E; Department of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden., Marin Navarro A; Department of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden., Zhou L; Department of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden., Sundström A; Department of Immunology, Genetics, and Pathology, Science For Life Laboratory, Uppsala University, 751 85 Uppsala, Sweden., van Bree N; Department of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden., Stantic M; Department of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden., Moslem M; Department of Neuroscience, Karolinska Institutet, 171 65 Stockholm, Sweden., Tailor J; Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.; Division of Neurosurgery, University of Toronto, Toronto, ON M5S 1A8, Canada., Rietdijk J; Department of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden., Zubillaga V; Department of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden., Hübner JM; Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), and German Cancer Research Consortium (DKTK), 69120 Heidelberg, Germany., Weishaupt H; Department of Immunology, Genetics, and Pathology, Science For Life Laboratory, Uppsala University, 751 85 Uppsala, Sweden., Wolfsberger J; Department of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden., Alafuzoff I; Department of Immunology, Genetics, and Pathology, Science For Life Laboratory, Uppsala University, 751 85 Uppsala, Sweden., Nordgren A; Department of Molecular Medicine and Surgery, Center for Molecular Medicine, Karolinska Institutet, 171 76 Stockholm, Sweden.; Department of Clinical Genetics, Karolinska University Hospital, 171 76 Stockholm, Sweden., Magnaldo T; Institute for Research on Cancer and Aging, CNRS UMR 7284, INSERM U1081, University of Nice Sophia Antipolis, Nice, France., Siesjö P; Division of Neurosurgery, Department of Clinical Sciences, Skane University Hospital, 221 85 Lund, Sweden.; Glioma Immunotherapy Group, Division of Neurosurgery, Department of Clinical Sciences, Lund University, 221 85 Lund, Sweden., Johnsen JI; Department of Women's and Children's Health, Karolinska Institutet, 171 76 Stockholm, Sweden., Kool M; Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), and German Cancer Research Consortium (DKTK), 69120 Heidelberg, Germany., Tammimies K; Department of Women's and Children's Health, Karolinska Institutet, 171 76 Stockholm, Sweden., Darabi A; Glioma Immunotherapy Group, Division of Neurosurgery, Department of Clinical Sciences, Lund University, 221 85 Lund, Sweden., Swartling FJ; Department of Immunology, Genetics, and Pathology, Science For Life Laboratory, Uppsala University, 751 85 Uppsala, Sweden., Falk A; Department of Neuroscience, Karolinska Institutet, 171 65 Stockholm, Sweden; margareta.wilhelm@ki.se anna.falk@ki.se., Wilhelm M; Department of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden; margareta.wilhelm@ki.se anna.falk@ki.se.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Aug 18; Vol. 117 (33), pp. 20127-20138. Date of Electronic Publication: 2020 Aug 03.
Publikováno v:
International Journal of Hyperthermia. 17:337-346
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe766898a78b28ad4b4d5e883a9aba81
https://doi.org/10.1080/02656730117221
https://doi.org/10.1080/02656730117221
Autor:
Ma, Qiang1 (AUTHOR), Hao, Shuai2,3 (AUTHOR), Hong, Weilong2 (AUTHOR), Tergaonkar, Vinay4 (AUTHOR), Sethi, Gautam5 (AUTHOR) phcgs@nus.edu.sg, Tian, Yu6 (AUTHOR) Tian_Yu@ben.edu, Duan, Chenyang2 (AUTHOR) duanchenyang1991@cqmu.edu.cn
Publikováno v:
Experimental Hematology & Oncology. 7/16/2024, Vol. 13 Issue 1, p1-28. 28p.
Publikováno v:
Radiotherapy and oncology, 22(4), 290-298. Elsevier Ireland Ltd
The EORTC trial 22881/10882 is a randomised trial with the aim to assess the role of the boost dose in breast conserving therapy in stage I and II breast cancer. In order to detect potential protocol deviations concerning irradiation technique and in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::e1a26fc3b9eccbacc3d2edaf1857a9f8
https://pure.amc.nl/en/publications/quality-assurance-of-the-eortc-trial-2288110882-assessment-of-the-role-of-the-booster-dose-in-breast-conserving-therapy-the-dummy-run-eortc-radiotherapy-cooperative-group(3292d84b-cdfd-4f8f-819a-0efadaec1723).html
https://pure.amc.nl/en/publications/quality-assurance-of-the-eortc-trial-2288110882-assessment-of-the-role-of-the-booster-dose-in-breast-conserving-therapy-the-dummy-run-eortc-radiotherapy-cooperative-group(3292d84b-cdfd-4f8f-819a-0efadaec1723).html
Autor:
Temmerman L; Experimental Vascular Pathology, Department of Pathology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands. lieve.temmerman@mumc.nl., Westra MM; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., Bot I; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., van Vlijmen BJM; Department of Thrombosis Hemostasis, Leiden University Medical Centre, Leiden, The Netherlands., van Bree N; Experimental Vascular Pathology, Department of Pathology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands., Bot M; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., Habets KLL; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., Keulers TGH; Department of Radiotherapy (MAASTRO)/GROW, School for Developmental Biology and Oncology, Maastricht University, Maastricht, The Netherlands., van der Vlag J; Department of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands., Cotter TG; Cell Development and Disease Laboratory, Department of Biochemistry, Biosciences Research Institute, University College Cork, Cork, Ireland., van Berkel TJC; Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., Biessen EAL; Experimental Vascular Pathology, Department of Pathology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.; Institute for Molecular Cardiovascular Research (IMCAR), University Hospital RWTH, Aachen, Germany.
Publikováno v:
Scientific reports [Sci Rep] 2017 Jun 08; Vol. 7 (1), pp. 3086. Date of Electronic Publication: 2017 Jun 08.
Autor:
Magrath, Justin W.1 (AUTHOR), Flinchum, Dane A.1 (AUTHOR), Hartono, Alifiani B.1,2 (AUTHOR), Sampath, Shruthi Sanjitha1 (AUTHOR), O'Grady, Tina M.1 (AUTHOR), Baddoo, Melody1 (AUTHOR), Haoyang, Liang1 (AUTHOR), Xu, Xiaojiang1 (AUTHOR), Flemington, Erik K.1 (AUTHOR), Lee, Sean B.1 (AUTHOR) slee30@tulane.edu
Publikováno v:
Oncogenesis. 1/4/2024, Vol. 13 Issue 1, p1-15. 15p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.